Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study

J. Enghelmayer (Buenos Aires, Argentina), F. Vivero (Mar del Plata, Argentina), S. Leiva Aguero (La Rioja, Argentina), S. Quadrelli (Buenos Aires, Argentina), D. Lancelloti (Mar del Plata, Argentina), F. Campins (Mar del Plata, Argentina), J. Sebastiani (Mar del Plata, Argentina), P. Malfante (Mar del Plata, Argentina), E. Gandara (Mar del Plata, Argentina), V. Basso (Mar del Plata, Argentina), M. Romiti (Mar del Plata, Argentina), A. Gaser (Buenos Aires, Argentina), M. Sacnun (Rosario, Argentina), F. Zenon (Buenos Aires, Argentina), R. Gomez (Buenos Aires, Argentina), P. Aruj (Buenos Aires, Argentina), F. Pacello (Paysandu, Uruguay), N. Naval (Tucuman, Argentina), V. Moyano (Cordoba, Argentina), J. Maritano (Buenos Aires, Argentina), M. Alberti (Buenos Aires, Argentina), F. Paulin (Buenos Aires, Argentina), M. Usandivaras (Tucuman, Argentina), S. Auteri (Rosario, Argentina), C. Isnardi (Buenos Aires, Argentina), G. Tabaj (Buenos Aires, Argentina), B. Varela (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina), S. Altube (Buenos Aires, Argentina), M. Lagrutta (Rosario, Argentina), J. Abdala (Mendoza, Argentina), C. Lilian (Buenos Aires, Argentina), L. Molinari (Rio Negro, Argentina), B. Gil (Tucuman, Argentina), M. Otaola (Buenos Aires, Argentina)

Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Enghelmayer (Buenos Aires, Argentina), F. Vivero (Mar del Plata, Argentina), S. Leiva Aguero (La Rioja, Argentina), S. Quadrelli (Buenos Aires, Argentina), D. Lancelloti (Mar del Plata, Argentina), F. Campins (Mar del Plata, Argentina), J. Sebastiani (Mar del Plata, Argentina), P. Malfante (Mar del Plata, Argentina), E. Gandara (Mar del Plata, Argentina), V. Basso (Mar del Plata, Argentina), M. Romiti (Mar del Plata, Argentina), A. Gaser (Buenos Aires, Argentina), M. Sacnun (Rosario, Argentina), F. Zenon (Buenos Aires, Argentina), R. Gomez (Buenos Aires, Argentina), P. Aruj (Buenos Aires, Argentina), F. Pacello (Paysandu, Uruguay), N. Naval (Tucuman, Argentina), V. Moyano (Cordoba, Argentina), J. Maritano (Buenos Aires, Argentina), M. Alberti (Buenos Aires, Argentina), F. Paulin (Buenos Aires, Argentina), M. Usandivaras (Tucuman, Argentina), S. Auteri (Rosario, Argentina), C. Isnardi (Buenos Aires, Argentina), G. Tabaj (Buenos Aires, Argentina), B. Varela (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina), S. Altube (Buenos Aires, Argentina), M. Lagrutta (Rosario, Argentina), J. Abdala (Mendoza, Argentina), C. Lilian (Buenos Aires, Argentina), L. Molinari (Rio Negro, Argentina), B. Gil (Tucuman, Argentina), M. Otaola (Buenos Aires, Argentina). Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study. 806

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry
Source: International Congress 2016 – Paediatric bronchology I
Year: 2016


Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Castleman disease variant of atypical POEMS syndrome: A case presentatIon
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014

Familial pulmonary fibrosis: Clinical-functional and radiological features
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Rituximab in the management of idiopathic inflammatory myopathies complicated by interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013


Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011



A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Hughes-Stovin syndrome: A case report
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015


Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema?
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009

A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Dermato-pulmonary syndrome associated with MDA-5 antibodies: Report of the first French series
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Longitudinal clinico-physiological behaviour of interstitial lung disease in the idiopathic inflammatory muscle syndromes
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010

Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Rituximab therapy for interstitial lung disease in patients with antisynthetase syndrome
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Interstitial lung diseases in childhood
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213
Year: 2002

Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013